May 30, 10:14 AM EDT
Media & Culture
Novartis Clinches Alcon In $12.9 Bln Deal
on 12/15/10 AT 10:11 AM
Swiss drug maker Novartis will pay $12.9 billion to buy the remaining shares of Alcon it doesn't already own to broaden its presence in the booming eye-care market, which is expected to outgrow the pharmaceuticals market in coming years.
Alcon squeeze-out bitter pill for minority holders
By IBT Staff Reporter on 01/05/10 AT 1:40 PM
Swiss drugmaker Novartis (NOVN.VX) is taking a rare stance in the M&A world by lowballing Alcon's minority shareholders.